# Shire clinical trials: 351 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 351 trials with Shire as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Shire: 351 rows for $17.55, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/shire

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 351
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 351, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 23, 2023 | NCT05870605 | Drug Use Study With Intuniv® in European Countries | Shire | Observational | Completed | Attention Deficit Hyperactivity Disorder (ADHD) | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05870605) |
| September 27, 2022 | NCT05556629 | A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA | Shire | Observational | Completed | Hypoparathyroidism | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05556629) |
| October 5, 2021 | NCT05067868 | A Study of Replagal in Children and Adults With Fabry Disease in India | Shire | Phase 4 | Recruiting | Fabry Disease | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05067868) |
| April 29, 2021 | NCT04866043 | Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder | Shire | Observational | Completed | Binge-eating Disorder | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04866043) |
| April 29, 2021 | NCT04866030 | Drug Use Study With Intuniv® in Australia | Shire | Observational | Completed | Attention Deficit Hyperactivity Disorder (ADHD) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04866030) |
| April 12, 2021 | NCT04840667 | A Study of Replagal in Treatment-naïve Adults With Fabry Disease | Shire | Phase 3 | Terminated | Fabry Disease | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04840667) |
| November 19, 2020 | NCT04636502 | Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA... | Shire | Observational | Completed | Primary Immunodeficiencies (PID) | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04636502) |
| October 12, 2020 | NCT04583007 | Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With... | Shire | Not applicable | No longer available | Hereditary Angioedema (HAE), Angioedema | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04583007) |
| August 4, 2020 | NCT04497883 | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese... | Shire | Phase 1 | Completed | Healthy Volunteers | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04497883) |
| July 10, 2020 | NCT04465396 | A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy... | Shire | Phase 1 | Completed | Healthy Volunteers | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04465396) |
| July 7, 2020 | NCT04460105 | Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia | Shire | Phase 1 | Withdrawn | COVID-19 Pneumonia | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04460105) |
| June 24, 2020 | NCT04444895 | A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal... | Shire | Phase 3 | Completed | Angioedema | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04444895) |
| June 19, 2020 | NCT04440488 | ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study | Shire | Phase 4 | Withdrawn | Chronic Obstructive Pulmonary Disease, Alpha1-antitrypsin Deficiency | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04440488) |
| June 12, 2020 | NCT04429984 | Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India | Shire | Observational | Completed | Gaucher Disease | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04429984) |
| November 27, 2019 | NCT04180163 | Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE) | Shire | Phase 3 | Completed | Hereditary Angioedema (HAE) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04180163) |
| October 18, 2019 | NCT04131556 | A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to... | Shire | Phase 1 | Terminated | Healthy Volunteers | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04131556) |
| October 17, 2019 | NCT04130191 | A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II | Shire | Observational | Completed | Hereditary Angioedema (HAE) | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04130191) |
| September 18, 2019 | NCT04094181 | A Study of VPRIV in Participants With Gaucher Disease Previously Treated With Other Enzyme Replacement Therapies or Substrate Reduction... | Shire | Observational | Terminated | Gaucher Disease | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04094181) |
| September 11, 2019 | NCT04085172 | A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) | Shire | Phase 4 | Completed | Attention Deficit Hyperactivity Disorder | 396 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04085172) |
| August 28, 2019 | NCT04070326 | A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children | Shire | Phase 3 | Completed | Hereditary Angioedema | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04070326) |
| August 15, 2019 | NCT04057131 | FIRAZYR General Drug Use-Results Survey (Japan) | Shire | Observational | Completed | Hereditary Angioedema (HAE) | 179 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04057131) |
| June 25, 2019 | NCT03997760 | A Study of SHP655 (rADAMTS13) in Sickle Cell Disease | Shire | Phase 1 | Completed | Sickle Cell Disease | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03997760) |
| April 19, 2019 | NCT03922308 | Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) | Shire | Phase 2 | Completed | Acquired Thrombotic Thrombocytopenic Purpura (aTTP) | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03922308) |
| April 17, 2019 | NCT03918239 | A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the... | Shire | Phase 1 | Completed | Healthy Volunteers | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03918239) |
| March 25, 2019 | NCT03888755 | A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants | Shire | Phase 3 | Completed | Hereditary Angioedema (HAE) | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03888755) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 57 |
| Phase 1/2 | 10 |
| Phase 2 | 63 |
| Phase 2/3 | 7 |
| Phase 3 | 140 |
| Phase 4 | 29 |
| Not applicable | 3 |
| Observational | 42 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 294 |
| Terminated | 41 |
| Withdrawn | 10 |
| No longer available | 2 |
| Recruiting | 2 |
| Active not recruiting | 1 |
| Approved for marketing | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Attention Deficit Disorder with Hyperactivity | 47 |
| Angioedemas, Hereditary | 39 |
| Colitis, Ulcerative | 16 |
| Mucopolysaccharidosis II | 15 |
| Short Bowel Syndrome | 15 |
| Gaucher Disease | 14 |
| Fabry Disease | 12 |
| Hypoparathyroidism | 11 |
| Kidney Failure, Chronic | 10 |
| Lysosomal Storage Diseases | 9 |
| Crohn Disease | 9 |
| Thrombocythemia, Essential | 8 |
| Leukodystrophy, Metachromatic | 7 |
| Sudden Infant Death | 7 |
| Hyperphagia | 6 |
| Binge-Eating Disorder | 6 |
| Depressive Disorder, Major | 6 |
| Mucopolysaccharidosis III | 6 |
| Dry Eye Syndromes | 5 |
| Osteoporosis | 5 |
| Eosinophilic Esophagitis | 5 |
| Schizophrenia | 5 |
| Mucopolysaccharidoses | 5 |
| Spasm | 4 |
| Angioedema | 4 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Cardiothoracic surgery practices in the United States](https://specstream.ai/data/businesses/cardiothoracic-surgery-practices/united-states)
- [Educational supply stores in the United States](https://specstream.ai/data/businesses/educational-supply-stores/united-states)
- [Hardware and fastener manufacturers in the United States](https://specstream.ai/data/businesses/hardware-and-fastener-manufacturers/united-states)
- [Lumber stores in the United States](https://specstream.ai/data/businesses/lumber-stores/united-states)
- [Peruvian restaurants in the United States](https://specstream.ai/data/businesses/peruvian-restaurants/united-states)
- [Sleep medicine clinics in the United States](https://specstream.ai/data/businesses/sleep-medicine-clinics/united-states)
